亚洲在线日韩伦理片,96精品国产AⅤ一区二区,青鸟影视网,yy黄色频道,国内精品久久久精品AV电影院
Products
News
Resources
Contact
Language
簡體中文
繁體中文
English
日(ri)本語
???
Ti?ng Vi?t
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Jacobio Pharma Announces 2025 Interim Results
2025-08-30 00:25
Jacobio Pharma Announces 2024 Annual Results
2025-03-19 21:42
The Registrational Clinical Data of Glecirasib was Published in Nature Medicine
2025-01-07 08:30
Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
2024-12-09 08:42
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China
2024-08-30 19:34
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
2024-06-02 08:25
Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint
2024-05-01 08:59
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting
2024-04-09 19:59
Jacobio Pharma Announces 2023 Annual Results
2024-03-29 08:50
Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30300 in the U.S.
2024-03-01 14:55
Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor
2024-02-18 20:50
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI
2024-01-20 06:30
Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with JAB-3312 at ESMO
2023-10-22 15:05
Jacobio Pharma Announces 2023 Interim Results
2023-08-30 21:45
Jacobio Pharma Announces Breakthrough Therapy Designation from China CDE for KRAS G12C Inhibitor Glecirasib for the Treatment of Pancreatic Cancer
2023-08-07 20:03
Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference
2023-07-21 10:19
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China
2023-07-04 21:16
Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer
2023-06-29 16:31
Jacobio Pharma Announces 2022 Annual Results
2023-03-22 22:38
Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA? (pembrolizumab) for patients with cancer
2023-03-22 12:36
1
2